Vital Farms, Inc. (NASDAQ:VITL - Get Free Report) has received an average recommendation of "Moderate Buy" from the six ratings firms that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $39.20.
Several equities research analysts have issued reports on the stock. Jefferies Financial Group decreased their price target on shares of Vital Farms from $45.00 to $41.00 and set a "buy" rating on the stock in a research note on Monday, November 11th. TD Cowen lowered their target price on shares of Vital Farms from $46.00 to $41.00 and set a "buy" rating for the company in a research note on Friday, November 8th. Finally, DA Davidson increased their price target on Vital Farms from $44.00 to $48.00 and gave the stock a "buy" rating in a research note on Thursday, October 10th.
Get Our Latest Report on VITL
Insider Activity
In other news, insider Matthew Ohayer sold 24,000 shares of the stock in a transaction dated Monday, October 21st. The shares were sold at an average price of $39.09, for a total transaction of $938,160.00. Following the transaction, the insider now owns 7,194,777 shares of the company's stock, valued at approximately $281,243,832.93. This trade represents a 0.33 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Russell Diez-Canseco sold 44,653 shares of the business's stock in a transaction dated Monday, October 14th. The shares were sold at an average price of $40.07, for a total value of $1,789,245.71. Following the completion of the sale, the chief executive officer now directly owns 537,349 shares of the company's stock, valued at approximately $21,531,574.43. This represents a 7.67 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 27.60% of the company's stock.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of VITL. Price T Rowe Associates Inc. MD raised its position in shares of Vital Farms by 5.6% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,510 shares of the company's stock worth $617,000 after purchasing an additional 1,402 shares during the period. Tidal Investments LLC bought a new stake in Vital Farms in the first quarter valued at $245,000. Cetera Advisors LLC acquired a new position in shares of Vital Farms during the first quarter valued at $481,000. CWM LLC grew its position in shares of Vital Farms by 162.9% during the second quarter. CWM LLC now owns 1,057 shares of the company's stock worth $49,000 after acquiring an additional 655 shares during the last quarter. Finally, SG Americas Securities LLC bought a new position in shares of Vital Farms during the second quarter worth about $2,300,000. 98.59% of the stock is currently owned by institutional investors.
Vital Farms Price Performance
Shares of VITL stock traded up $0.97 during midday trading on Friday, reaching $35.44. 521,300 shares of the company traded hands, compared to its average volume of 1,217,498. The firm has a market cap of $1.55 billion, a PE ratio of 31.64 and a beta of 0.93. The company has a debt-to-equity ratio of 0.04, a current ratio of 3.24 and a quick ratio of 2.81. The firm's 50 day simple moving average is $34.68 and its two-hundred day simple moving average is $36.52. Vital Farms has a 1-year low of $14.09 and a 1-year high of $48.41.
Vital Farms (NASDAQ:VITL - Get Free Report) last issued its quarterly earnings data on Thursday, November 7th. The company reported $0.16 EPS for the quarter, beating analysts' consensus estimates of $0.14 by $0.02. Vital Farms had a net margin of 8.68% and a return on equity of 22.29%. The firm had revenue of $145.00 million for the quarter, compared to analysts' expectations of $145.27 million. During the same period in the prior year, the company earned $0.10 EPS. The firm's revenue was up 31.3% on a year-over-year basis. On average, equities research analysts expect that Vital Farms will post 1.11 EPS for the current fiscal year.
About Vital Farms
(
Get Free ReportVital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
Read More
Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.